X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7411) 7411
Book Review (956) 956
Publication (575) 575
Book Chapter (16) 16
Dissertation (5) 5
Conference Proceeding (4) 4
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6578) 6578
index medicus (6541) 6541
female (5101) 5101
male (4723) 4723
middle aged (4723) 4723
oncology (4443) 4443
aged (4356) 4356
chemoradiotherapy (3805) 3805
radiotherapy (3545) 3545
chemotherapy (3464) 3464
cancer (3413) 3413
adult (3368) 3368
treatment outcome (2500) 2500
surgery (2149) 2149
care and treatment (1985) 1985
neoplasm staging (1839) 1839
retrospective studies (1743) 1743
aged, 80 and over (1675) 1675
antineoplastic combined chemotherapy protocols - therapeutic use (1661) 1661
chemoradiotherapy - adverse effects (1632) 1632
radiation-therapy (1491) 1491
disease-free survival (1362) 1362
survival (1359) 1359
radiology, nuclear medicine & medical imaging (1317) 1317
carcinoma (1310) 1310
prognosis (1205) 1205
radiation (1202) 1202
hematology, oncology and palliative medicine (1144) 1144
chemoradiotherapy - methods (1142) 1142
combined modality therapy (1131) 1131
radiation therapy (1092) 1092
analysis (1083) 1083
cisplatin (1079) 1079
medicine & public health (1072) 1072
chemoradiation (1065) 1065
cisplatin - administration & dosage (1012) 1012
survival rate (990) 990
squamous-cell carcinoma (969) 969
antineoplastic combined chemotherapy protocols - adverse effects (964) 964
research (963) 963
follow-up studies (958) 958
therapy (944) 944
carcinoma, squamous cell - therapy (920) 920
patients (919) 919
toxicity (885) 885
radiotherapy dosage (879) 879
risk factors (847) 847
trial (847) 847
fluorouracil - administration & dosage (820) 820
kaplan-meier estimate (775) 775
neoadjuvant therapy (774) 774
esophageal cancer (770) 770
carcinoma, squamous cell - pathology (762) 762
health aspects (732) 732
prospective studies (709) 709
concurrent chemoradiotherapy (699) 699
randomized-trial (697) 697
survival analysis (690) 690
squamous cell carcinoma (687) 687
time factors (664) 664
colorectal cancer (648) 648
cancer therapies (611) 611
head and neck cancer (601) 601
metastasis (594) 594
adenocarcinoma - therapy (593) 593
young adult (588) 588
adenocarcinoma (582) 582
rectal neoplasms - pathology (573) 573
rectal cancer (567) 567
antineoplastic agents - therapeutic use (566) 566
rectal neoplasms - therapy (558) 558
carcinoma, squamous cell - mortality (551) 551
clinical trials (551) 551
cancer patients (548) 548
radiology (548) 548
tumors (548) 548
fluorouracil (545) 545
esophageal neoplasms - therapy (540) 540
patient outcomes (540) 540
gastroenterology & hepatology (536) 536
oncology, experimental (504) 504
head and neck neoplasms - therapy (503) 503
carcinoma, squamous cell - radiotherapy (501) 501
adenocarcinoma - pathology (497) 497
cisplatin - adverse effects (484) 484
multivariate analysis (476) 476
chemotherapy, adjuvant (474) 474
quality of life (468) 468
esophageal neoplasms - pathology (465) 465
chemoradiotherapy, adjuvant (461) 461
nuclear radiation (461) 461
carcinoma, squamous cell - drug therapy (458) 458
head (458) 458
neck-cancer (453) 453
induction chemotherapy (436) 436
antineoplastic agents - adverse effects (434) 434
phase-iii trial (428) 428
quality-of-life (425) 425
5-fluorouracil (417) 417
deoxycytidine - analogs & derivatives (417) 417
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7184) 7184
Japanese (66) 66
French (54) 54
German (41) 41
Chinese (37) 37
Russian (19) 19
Spanish (10) 10
Hungarian (5) 5
Turkish (2) 2
Danish (1) 1
Icelandic (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 2, pp. 341 - 348
Journal Article
Journal of Radiation Research, ISSN 0449-3060, 05/2015, Volume 56, Issue 3, pp. 568 - 576
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2013, Volume 31, Issue 31, pp. 3971 - 3979
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 25, pp. 2735 - 2743
Journal Article
Lung India, ISSN 0970-2113, 01/2019, Volume 36, Issue 1, pp. 32 - 37
Lung cancer (LC) chemotherapy results in several adverse events (AEs). Data regarding supportive care medications (SCMs) offered to prevent/treat AEs in... 
Adenocarcinoma | toxicity | chemoradiotherapy | malignancy | anemia | Care and treatment | Chemotherapy | Usage | Lung cancer | Diagnosis | Research | Cancer | Performance evaluation | Statistical analysis | Disease | Anemia | Industrialized nations | Histology | Hospitalization | Cancer therapies | Questionnaires | Expenditures | Mutation | Smoking | Tumors | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2015, Volume 33, Issue 4, pp. 332 - 339
Journal Article
Journal of Veterinary Internal Medicine, ISSN 0891-6640, 01/2009, Volume 23, Issue 1, pp. 24 - 30
Journal Article
JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | ADENOCARCINOMA | CHEMORADIOTHERAPY | FOLINIC ACID | MODEL | CHEMOTHERAPY | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Pancreatic Ductal - surgery | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Pancreatic cancer | Clinical trials | Product development | Metastasis | Comparative analysis | Antineoplastic agents | Studies | Antigens | Chemotherapy | Acids | Pragmatism | Pharmaceutical industry | Cancer therapies | Abdomen | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2012, Volume 30, Issue 3, pp. 268 - 273
Journal Article
Journal Article
Journal Article